
Astellas Cut Lab Tests by 90% in a Drug Screen Using Boltz-2
Boltz-2 helped Astellas narrow a drug screen to 10 compounds, all of which showed the desired activity in lab tests. The strongest performed comparably in the lab to a benchmark compound already in clinical trials.













